In the BioHarmony Drug Report Database

"Preview" Icon

Sulfinpyrazone

Anturane (sulfinpyrazone) is a small molecule pharmaceutical. Sulfinpyrazone was first approved as Anturane on 1982-01-01. It is used to treat angina pectoris, coronary disease, gout, and myocardial infarction in the USA. The pharmaceutical is active against solute carrier family 22 member 12. In addition, it is known to target fMet-Leu-Phe receptor.

 

Trade Name

 

Anturane
 

Common Name

 

sulfinpyrazone
 

ChEMBL ID

 

CHEMBL832
 

Indication

 

angina pectoris, coronary disease, gout, myocardial infarction
 

Drug Class

 

Image (chem structure or protein)

Sulfinpyrazone structure rendering